BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 12387979)

  • 1. Surgical resection with and without chemotherapy in oesophageal cancer.
    Chander S
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical resection with and without chemotherapy in oesophageal cancer.
    Rath GK; Sharma DN; Shukla NK
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387980
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical resection with and without chemotherapy in oesophageal cancer.
    Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
    Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical resection with and without chemotherapy in oesophageal cancer.
    Maraveyas A; O'Boyle C; Cowen M
    Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
    Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
    Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
    Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
    J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant treatment of operable esophageal cancers].
    Azria D; Ychou M; Senesse P; Dubois JB
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
    [No Abstract]   [Full Text] [Related]  

  • 12. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for esophageal cancer.
    Heath EI; Forastiere AA
    Cancer Treat Res; 2001; 105():387-98. PubMed ID: 11224996
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neoadjuvant therapy in oesophageal cancer surgery].
    Imdahl A
    Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A; Schöffel U; Ruf G; Hopf UT
    Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
    Delouche D; Haefliger JM
    Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
    [No Abstract]   [Full Text] [Related]  

  • 19. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
    Chua YJ; Cunningham D
    Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
    Hirst J; Smithers BM; Gotley DC; Thomas J; Barbour A
    Ann Surg Oncol; 2011 Jun; 18(6):1766-74. PubMed ID: 21213056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.